The formation of tight tumor clusters affects the efficacy of cell cycle inhibitors: a hybrid model study November 8, 2014 Read More »
Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients October 24, 2014 Visani G1, Ferrara F2, Di Raimondo F3, Loscocco F1, Sparaventi G1, Paolini S4, Fuligni F4, Gazzola A4, Rossi M4, Laginestra MA4, Caraci MR3, Riccardi C2,Rocchi M5, Visani A4, Pileri SA4, Piccaluga PP4, Isidori A1. Leukemia. 2014 Apr;28(4):967-70. Read More »
Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation October 5, 2014 Read More »
Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma September 24, 2014 Isfoss BL, Busch C, Hermelin H, Vermedal AT, Kile M, Braathen GJ, Majak B, Berner A. Virchows Arch. 2014 Apr;464(4):473-88. Read More »
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity September 19, 2014 Read More »
Signaling mediated by the NF-kB sub-units NF-kB1, NF-kB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice August 9, 2014 Oncogene. 2013 Dec 12;32(50):5563-73. Burkitt MD1, Williams JM1, Duckworth CA1, O’Hara A1, Hanedi A1, Varro A2, Caamaño JH3, Pritchard DM1. Read More »
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. August 1, 2014 Tabouret E, Boudouresque F, Barrie M, Matta M, Boucard C, Loundou A, Carpentier A, Sanson M, Metellus P, Figarella-Branger D, Ouafik L, Chinot O. Neuro Oncol. 2014 Mar;16(3):392-9. Read More »
Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice. June 23, 2014 Burkitt MD, Williams JM, Duckworth CA, O’Hara A, Hanedi A, Varro A, Caamaño JH, Pritchard DM. Oncogene. 2013 Dec 12;32(50):5563-73. Read More »
The Anti-Tumor Activity of E1A and its Implications in Cancer Therapy. April 23, 2014 Chang YW, Hung MC, Su JL. Arch Immunol Ther Exp (Warsz). 2014 Feb 7. Read More »
NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma. April 3, 2014 Watanabe M, Ohnishi Y, Inoue H, Wato M, Tanaka A, Kakudo K, Nozaki M. Oncol Lett. 2014;7(1):35-40. Read More »
Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi’s sarcoma-associated herpes virus associated malignancies. March 21, 2014 Paul AG, Chandran B, Sharma-Walia N. Transl Res. 2013;162(2):77-92. Read More »
Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. March 16, 2014 Nakamura S, Nagano S, Nagao H, Ishidou Y, Yokouchi M, Abematsu M, Yamamoto T, Komiya S, Setoguchi T. PLoS One. 2013;8(7):e69466. Read More »
Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models. January 29, 2014 Portwood S, Lal D, Hsu YC, Vargas R, Johnson MK, Wetzler M, Hart CP, Wang ES. Clin Cancer Res. 2013 ;19(23):6506-19. Read More »
Transoral videolaryngoscopic surgery for oropharyngeal, hypopharyngeal, and supraglottic cancer. December 10, 2013 Tomifuji M, Araki K, Yamashita T, Shiotani A. Eur Arch Otorhinolaryngol. 2013 Jun 1. Read More »